Last update June 23, 2022
Limited compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
メシル酸チオプロペラジン is Thioproperazine Mesilate in Japanese.
Is written in other languages:メシル酸チオプロペラジン is also known as
メシル酸チオプロペラジン belongs to these groups or families:
Main tradenames from several countries containing メシル酸チオプロペラジン in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Typical, first-generation antipsychotic. It is a phenothiazine with properties similar to those of chlorpromazine. It is used in the treatment of schizophrenia, mania, and other psychoses. Single-dose oral administration.
At the date of the last update, there was no published data available on its excretion in human milk.
Product with very few and old bibliographic references, without known pharmacokinetic data and marketed in few countries.
It can cause galactorrhea. (Mendels 1964)
Known safer alternatives are preferable (Parikh 2014), especially during the neonatal period and in the event of prematurity.
See below the information of this related product: